219 related articles for article (PubMed ID: 27913478)
1. Thrombosis in the setting of obesity or inflammatory bowel disease.
Lentz SR
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):180-187. PubMed ID: 27913478
[TBL] [Abstract][Full Text] [Related]
2. Thrombosis in the setting of obesity or inflammatory bowel disease.
Lentz SR
Blood; 2016 Nov; 128(20):2388-2394. PubMed ID: 27856470
[TBL] [Abstract][Full Text] [Related]
3. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
[TBL] [Abstract][Full Text] [Related]
4. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention.
Zitomersky NL; Verhave M; Trenor CC
Inflamm Bowel Dis; 2011 Jan; 17(1):458-70. PubMed ID: 20848518
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
Dwyer JP; Javed A; Hair CS; Moore GT
Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
[TBL] [Abstract][Full Text] [Related]
6. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
[TBL] [Abstract][Full Text] [Related]
7. Etiopathogenesis, Prevention, and Treatment of Thromboembolism in Inflammatory Bowel Disease.
Alkim H; Koksal AR; Boga S; Sen I; Alkim C
Clin Appl Thromb Hemost; 2017 Sep; 23(6):501-510. PubMed ID: 26893444
[TBL] [Abstract][Full Text] [Related]
8. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.
Zitomersky NL; Levine AE; Atkinson BJ; Harney KM; Verhave M; Bousvaros A; Lightdale JR; Trenor CC
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):343-7. PubMed ID: 23752078
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic inflammatory bowel disease as a prothrombotic state].
Kamenář D; Špičák J
Vnitr Lek; 2016; 62(5):384-91. PubMed ID: 27319231
[TBL] [Abstract][Full Text] [Related]
10. Overview of venous thrombosis in inflammatory bowel disease.
Purnak T; Yuksel O
Inflamm Bowel Dis; 2015 May; 21(5):1195-203. PubMed ID: 25581828
[TBL] [Abstract][Full Text] [Related]
11. Venous and arterial thromboembolism in patients with inflammatory bowel diseases.
Stadnicki A; Stadnicka I
World J Gastroenterol; 2021 Oct; 27(40):6757-6774. PubMed ID: 34790006
[TBL] [Abstract][Full Text] [Related]
12. Prevention of venous thromboembolism in hospitalized patients with inflammatory bowel disease.
Chande N
Inflamm Bowel Dis; 2013 Mar; 19(3):669-71. PubMed ID: 23385239
[TBL] [Abstract][Full Text] [Related]
13. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.
Olivera PA; Zuily S; Kotze PG; Regnault V; Al Awadhi S; Bossuyt P; Gearry RB; Ghosh S; Kobayashi T; Lacolley P; Louis E; Magro F; Ng SC; Papa A; Raine T; Teixeira FV; Rubin DT; Danese S; Peyrin-Biroulet L
Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):857-873. PubMed ID: 34453143
[TBL] [Abstract][Full Text] [Related]
14. Therapy insight: Vascular complications in patients with inflammatory bowel disease.
Koutroubakis IE
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):266-72. PubMed ID: 16265230
[TBL] [Abstract][Full Text] [Related]
15. Duration of anticoagulation for the management of venous thromboembolism in inflammatory bowel disease: a decision analysis.
Nguyen GC; Bernstein CN
Am J Gastroenterol; 2013 Sep; 108(9):1486-95. PubMed ID: 23857476
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism in patients with inflammatory bowel disease.
Koutroumpakis EI; Tsiolakidou G; Koutroubakis IE
Semin Thromb Hemost; 2013 Jul; 39(5):461-8. PubMed ID: 23629820
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
18. Assessment of anti-prothrombin antibodies in thrombosis complicating inflammatory bowel diseases.
Saibeni S; Etchevers MJ; Tassies D; Panés J; Reverter JC; Danese S; Piqué JM; Bruno S; Vecchi M; Gasbarrini A; Sans M
Int J Colorectal Dis; 2013 Sep; 28(9):1281-6. PubMed ID: 23588875
[TBL] [Abstract][Full Text] [Related]
19. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
Bryant RV; Jairath V; Curry N; Travis SP
J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of thrombosis in obesity.
Blokhin IO; Lentz SR
Curr Opin Hematol; 2013 Sep; 20(5):437-44. PubMed ID: 23817170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
